Related Experiment Video
Updated: Jul 28, 2026

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
Glycochenodeoxycholic acid (GCDC) induced hepatocyte apoptosis is associated with early modulation of intracellular
B Gonzalez1, C Fisher, B G Rosser
1Liver Diseases Unit, University of Manitoba, Winnipeg, Canada.
Abstract:
The effect of GCDC-induced apoptosis on PKC activity and PKC's role in GCDC-induced hepatocyte apoptosis is unclear. The specific aims of this study were to determine if GCDC-induced apoptosis changed intracellular PKC activity and if modulation of PKC activity affected GCDC-induced hepatocyte apoptosis. Apoptosis was induced in isolated hepatocytes using GCDC. PKC activity was measured and specific PKC and calpain inhibitors were used to study the effects of PKC and calpain modulation on GCDC-induced apoptosis. After 4 h exposure, 50 microM GCDC induced apoptosis in 42% of hepatocytes. Intracellular PKC activity decreased to 44% of controls 2 h after exposure of hepatocytes to GCDC (p < 0.001). Pre-incubation of hepatocytes with the calpain protease inhibitor restored PKC activity in GCDC exposed hepatocytes to 91 +/- 5% of control cells. Pre-incubation of hepatocytes with a calpain inhibitor decreased GCDC-induced apoptosis as did pre-incubation with the PKC activating phorbol ester, PMA. The combination of calpain inhibition and PMA further reduced GCDC-induced apoptosis but caused low level hepatic apoptosis. Inhibition of PKC with chelerythrine also substantially reduced GCDC-induced hepatocyte apoptosis. GCDC-induced apoptosis is associated with decreases in total cellular PKC activity, which appear to be dependent on intracellular calpain-like protease activity. The combination of protease inhibition and phorbol ester pretreatment preserved total cellular PKC activity and decreased GCDC-induced apoptosis but induced low level apoptosis in the absence of GCDC exposure. PKC inhibition also decreased GCDC-induced hepatocyte apoptosis highlighting the complex interactions of PKC and proteases during GCDC-induced apoptosis.
Insights
This study reveals that GCDC-induced apoptosis decreases protein kinase C (PKC) activity, a process dependent on calpain proteases. Modulating PKC and calpain activity impacts hepatocyte apoptosis, offering insights into liver cell death mechanisms.
Area of Science:
- Hepatology
- Cell Biology
- Biochemistry
Background:
- The role of protein kinase C (PKC) activity in GCDC-induced hepatocyte apoptosis remains unclear.
- Investigating the interplay between GCDC, apoptosis, and PKC is crucial for understanding liver injury.
Purpose of the Study:
- To determine if GCDC exposure alters intracellular PKC activity.
- To investigate the effect of modulating PKC activity on GCDC-induced hepatocyte apoptosis.
Main Methods:
- Hepatocytes were exposed to GCDC to induce apoptosis.
- PKC activity was measured using biochemical assays.
- Specific PKC and calpain inhibitors, along with PMA, were used to modulate signaling pathways.
Main Results:
- GCDC exposure significantly decreased intracellular PKC activity in hepatocytes.
- Calpain inhibition restored PKC activity and reduced GCDC-induced apoptosis.
- PKC activation (PMA) and inhibition (chelerythrine) both modulated GCDC-induced apoptosis, indicating complex interactions.
Conclusions:
- GCDC-induced hepatocyte apoptosis is linked to reduced PKC activity, mediated by calpain proteases.
- Targeting PKC and calpain pathways offers potential therapeutic strategies for GCDC-induced liver injury.
- The study highlights the complex, bidirectional relationship between PKC, calpain activity, and apoptosis in hepatocytes.
More Related Videos
Related Concept Videos
The Extrinsic Apoptotic Pathway
GPCR Desensitization
cAMP-dependent Protein Kinase Pathways
Cellular Injury V: Apoptosis and Autophagy

